首页> 外文OA文献 >miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer

【2h】

miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer

机译：MiR-375通过降解人氏阳性乳腺癌中的HoxB3来抑制癌症干细胞表型和三种毒素抗性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hui Fu; Lei Fu; Chao Xie; Wen-Shu Zuo; Yan-Song Liu; Mei-Zhu Zheng; Jin-Ming Yu;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer [J] . Fu Hui, Fu Lei, Xie Chao, Oncology reports . 2017,第2期

机译：MiR-375通过降解人类抗乳腺癌中的HoxB3来抑制癌症干细胞表型和他莫昔芬抗性
2. STAT3 mediates resistance of CD44~＋CD24~（-/low） breast cancer stem cells to tamoxifen in vitroSTAT3 mediates resistance of CD44~＋CD24~（-/low） breast cancer stem cells to tamoxifen in vitroSTAT3 mediates resistance of CD44＋CD24（-/low） breast cancer stem cells to tamoxifen in vitro [J] . Xiaoyan Wang, Guozhu Wang, Yi Zhao, 生物医学研究杂志：英文版 . 2012,第005期

机译：STAT3介导CD44〜＋ CD24〜（-/ low）乳腺癌干细胞对他莫昔芬的抗性STAT3介导CD44〜＋ CD24〜（-/ low）乳腺癌干细胞对他莫昔芬的抗性乳腺癌干细胞体外他莫昔芬
3. Tamoxifen enhances the anti-proliferative effect of roscovitine, a selective cyclin-dependent kinase inhibitor, on human ER-positive human breast cancer cells [J] . GritschD., MaurerM., ZulehnerN., Journal of experimental therapeutics & oncology . 2011,第1期

机译：他莫昔芬增强了roscovitine，一种选择性细胞周期蛋白依赖性激酶抑制剂的抗增殖作用，对人体ER阳性人乳腺癌细胞
4. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone [C] . World congress on breast diseases . 2008

机译：一种新型小鼠模型的人乳腺癌干燥细胞，具有高CD44 + CD24- /较低的人骨表型转移
5. G Protein-coupled Estrogen Receptor 1 (GPER1) and Insulin-like Growth Factor Binding Protein 1 (IGFBP-1) Are Key Components of Tamoxifen Action and the Development of Tamoxifen Resistance in Breast Cancer Cells [D] . Zheng, Yan. 2019

机译：G蛋白偶联雌激素受体1（GPER1）和胰岛素样生长因子结合蛋白1（IGFBP-1）是他莫昔芬作用的关键组分和乳腺癌细胞中他莫昔芬抗性的发育
6. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells [O] . Jie Yuan, Manran Liu, Li Yang, 2015

机译：他莫昔芬抗性乳腺癌细胞上皮-间质转化表型的获得：G蛋白偶联雌激素受体通过肿瘤相关的成纤维细胞衍生纤连蛋白和β1-整合素信号通路介导他莫昔芬抗性的新作用
7. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells [O] . 2015

机译：他莫昔芬抗性乳腺癌细胞上皮-间质转化表型的获得：G蛋白偶联雌激素受体通过肿瘤相关的成纤维细胞衍生纤连蛋白和β1-整合素信号通路介导他莫昔芬抗性的新作用

miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅